Alvotech
ALVO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $157.4M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVOW
Q2 2024 vs. Q1 2024
How the institutions holding Alvotech changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 22 | 31 | +9 |
| Shares | 14.3M | 14.5M | +243.5K (+1.7%) |
| Value | $172.4M | $174.0M | +$1.57M (+0.9%) |
New holders (11)
Institutions that held Alvotech at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 848,444 | $10.3M | 0.03% |
| PointState Capital LP | 730,072 | $8.88M | 0.25% |
| Legal & General Group Plc | 543,865 | $6.42M | 0.00% |
| Millennium Management LLC | 116,018 | $1.41M | 0.00% |
| Exome Asset Management LLC | 99,000 | $1.20M | 1.07% |
| Royce & Associates LP | 94,000 | $1.14M | 0.01% |
| TBH Global Asset Management, LLC | 33,500 | $407.4K | 0.09% |
| Richmond Brothers, Inc. | 13,966 | $169.8K | 0.34% |
| Goldman Sachs Group Inc | 11,656 | $141.7K | 0.00% |
| Quarry LP | 1,184 | $14.4K | 0.01% |
| Advisor Group Holdings, Inc. | 150 | $1.82K | 0.00% |
Sold out (2)
Institutions that held Alvotech at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Occudo Quantitative Strategies LP | 24,120 | $294.7K |
| Point72 Asset Management, L.P. | 11,700 | $143.0K |